Trinity Biotech (TRIBY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY)

TRIB 0.960

-9.4%

12:54 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Keiko who wrote (9621)	7/2/1998 11:33:00 AM
From: gbull	Read Replies (2) of 14328

That's what I thought, don't know what HIV2 is, but if it is a mutating strain, how would you catch it in a test with 99% above results. Would the FDA really stop a test because it wouldn't allow for a very small percentage of disease incidence. Because you can't find HIV2, does that mean you don't test? That was some of the underlying logic of the CDC report. Is the public being served by not having instantaneous tests if there are false positives and/or failure to spot (wasn't there a famous spot of blood in some English play?) HIV in a small # of cases. I believe their conclusion was that instantaneous tests will help control AIDS despite the small percentage possibility of error. I believe witholding HIV testing until HIV2 can be spotted would fall under the small analysis and be dismissed. I therefore agree with Greg, but I am too lazy to research the last 9000 posts. What's your educated opinion Greg? I would give you mine but I'd have to go find a education somewhere! GB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next